Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Ganciclovir for CMV Prevention in HIV
NCT00002095Phase 3Completed
- Sponsor
- Roche
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of ganciclovir in cytomegalovirus disease (CMV), sponsored by Roche. Status: completed.
02
Drugs
ganciclovir
03
Conditions
cytomegalovirus disease (CMV)
Beyond the preview
Go deeper on NCT00002095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002095.